GlassScriptPhysician profile
Vinod H Thourani
NPI 1851480412
$1,229,861.71
in general payments reported to CMS, 2019-2025
39 companies · $169K in 2025
The $169K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $131K · 2020: $354K · 2021: $156K · 2022: $146K · 2023: $112K · 2024: $162K · 2025: $169K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $310K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $72K · Travel and Lodging: $31K · Food and Beverage: $25K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,775 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $309,680.22 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $72,216.13 |
| Travel and Lodging | $31,048.86 |
| Food and Beverage | $24,526.94 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,775.00 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $584,433.48 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Mitris Resilia Mitral Valve |
| Z-Medica, LLC | $302,108.84 | 2019-2021 | |
| Abbott Laboratories | $205,682.37 | 2019-2025 | Mitraclip, Navitor, Amplatzer Amulet |
| Atricure, INC. | $32,414.25 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Boston Scientific Corporation | $31,472.23 | 2019-2024 | Sentinel, Avvigo Guidance System, Ekosonic |
| Arthrex, INC. | $31,265.13 | 2025 | |
| W. L. Gore & Associates, INC. | $14,908.80 | 2019-2021 | |
| Shockwave Medical, INC | $8,834.89 | 2020-2022 | |
| Artivion, INC. | $8,485.02 | 2020-2025 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder, Amds-Ascyrus Medical, Bioglue Surgical Adhesive |
| Pacira Pharmaceuticals Incorporated | $3,160.00 | 2022 | |
| Croivalve INC | $1,553.72 | 2023-2024 | |
| Jenavalve Technology, INC. | $1,299.75 | 2019-2023 | Jenavalve Pericardial Tavr System |
| Medtronic, INC. | $590.92 | 2021-2025 | Avalus, Penditure, Penditure |
| Pi-Cardia, INC. | $575.00 | 2025 | Shortcut |
| Corcym INC | $400.00 | 2024-2025 | Perceval |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $378.85 | 2024-2025 | |
| Getinge USA Sales, LLC | $346.37 | 2019-2024 | Vasoview Hemopro 2 |
| Abiomed | $318.29 | 2021-2024 | Impella |
| Saranas, INC. | $293.70 | 2022 | |
| United Orthopedics LLC | $252.45 | 2025 | |
| Medtronic Vascular, INC. | $193.74 | 2019-2020 | |
| Biotronik INC. | $134.69 | 2023 | Pk Papyrus, Orsiro Mission |
| E.R. Squibb & Sons, L.L.C. | $118.25 | 2023-2025 | Camzyos |
| Bolton Medical INC | $111.46 | 2025 | Gelweave |
| Stryker Corporation | $86.16 | 2024-2025 | Na |
| Baxter Healthcare | $69.91 | 2021-2025 | Floseal, Perclot |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $57.20 | 2024 | Lifevest |
| Angiodynamics, INC. | $48.86 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $40.78 | 2021-2024 | Giapreza |
| Pfizer INC. | $38.80 | 2025 | |
| Zimmer Biomet Holdings, INC. | $38.48 | 2019 | |
| Hemosonics LLC | $35.29 | 2020-2021 | |
| Lsi Solutions INC | $33.21 | 2022-2024 | Cor-Knot |
| Cvrx, INC. | $24.69 | 2025 | Barostim Neo System |
| Terumo Cardiovascular Systems Corporation | $15.96 | 2022 | |
| Biom'Up France Sas | $15.61 | 2020 | |
| Kestra Medical Technology Services, INC. | $13.15 | 2022 | |
| Lemaitre Vascular, INC. | $11.41 | 2023 | Anastoclip Gc 8cm (Medium) |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,800.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$7,200.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinod Thourani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.